Q
QuantAbundanciaAbundance, Quantified.

News

High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.

26,176 signal articles · 240 in last 24h · 125,753 total before filter · latest 26m ago
240last 24h
1177last 7d
165● bullish (7d)
129● bearish (7d)
205publishers
AllMacro225Earnings409M&A92Regulatory21Product9Analyst10
✕ clear all filterssentiment: neutralSentiment:bullishneutralbearish✓ showing all (incl. clickbait)
Could Broadcom (AVGO) Be 40% Undervalued As It Heads To Memory And Storage Conference?
Simply Wall St.22d agoneutral
Could Broadcom (AVGO) Be 40% Undervalued As It Heads To Memory And Storage Conference?

Broadcom (AVGO) is back in the spotlight as it prepares to present at the Future of Memory and Storage 2026 conference in Santa Clara, putting its data center and storage technology in front of industry specialists and investors. See our latest analysis for Broadcom. Recent moves suggest interest in Broadcom is rebuilding, with a 1-month share price return of 8.82% and a year to date share price gain of 12.83%. The 1-year total shareholder return is 34.88%, and the 5-year total shareholder...

McDonald's (MCD) Names Skye Anderson To Lead Its Crucial US Business
Simply Wall St.22d agoneutral
McDonald's (MCD) Names Skye Anderson To Lead Its Crucial US Business

McDonald's (NYSE:MCD) has appointed Skye Anderson as President of McDonald's USA. Anderson succeeds Joe Erlinger, a long-serving executive at the company. The leadership change affects McDonald's largest market in terms of systemwide sales. McDonald's remains one of the largest global quick service restaurant chains, with the U.S. as its core market. The appointment of Skye Anderson comes as the company responds to shifting consumer preferences, changing traffic patterns and a competitive...

BioNTech Q2 Earnings Call Highlights
MarketBeat22d agoneutral
BioNTech Q2 Earnings Call Highlights

BioNTech (NASDAQ:BNTX) reported second-quarter 2026 revenue of €106 million, down from €261 million a year earlier, as lower U.S. demand for its COVID-19 vaccine weighed on results. The prior-year quarter also benefited from a one-time compensation payment from Pfizer related to its decision to opt